Anavex Life Sciences Corp.

(AVXL) Trade

By |

Profile

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company operating in the United States. It is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer's disease, other central nervous systems (CNS) diseases, pain and several types of cancer. The lead compound of the company is ANAVEX 2-73 which is developed to treat Alzheimer's disease, Parkinson's disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome. The research and development pipeline of the company includes one clinical drug candidate and several compounds in various stages of the pre-clinical study.

Contact Information

Website: www.anavex.com
Email: scottg@coreir.com
Main Phone: +1 844 689-3939
Address: 51 West 52nd Street
Address 2: 7th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Christopher U. Missling
Employees: 10
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.10 $ -0.05 (-2.33%)
Last Price 2.10 Change $ -0.05 Change % -2.33 Tick N/A
Bid 2.02 Bid Size 1,000.00 Ask 2.44 Ask Size 2,000.00
Open 2.13 High 2.18 Low 2.05 Prev Close 2.15
Last Trade Volume 199,424 52 Wk Hi 4.35 52 Wk Low 1.85
Market Cap 95.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 45,431,305.00 EPS (TTM) -0.47 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 26
Number of Buys 0 26
Number of Sells 0 0
Net Activity 0 14960
Last 10 Buys Shares
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Christopher U. Missling 1,000
Last 10 Sell Shares
Harvey Lalach 1,000
Harvey Lalach 1,000
Harvey Lalach 1,000
Harvey Lalach 1,000
Harvey Lalach 1,000
Harvey Lalach 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 9.5 9.5 9.33 9.5
Standard Deviation 4.04 4.04 4.93 4.04
Date of Most Recent Estimate 05/31/18 05/31/18 05/17/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 2 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1